All Infectious Disease articles – Page 3
-
NewsResearchers discover first PLP-dependent enzyme that influences bacterial protein production
Researchers discovered aminovaleramididine synthetase (AvaS), the first pyridoxal phosphate (PLP)-dependent enzyme involved in tRNA modification, expanding scientific understanding of how RNA shapes the reading of genetic information. The discovery reveals a previously unknown mechanism that bacteria use to regulate protein production.
-
NewsWhat low vaccination rates in the US could mean for flu season 2026
Experts reveal what to expect this flu season, when to get the flu shot, how to recognize flu symptoms, how to treat it, and what the newly approved mRNA flu vaccine means for the public.
-
NewsThe Wistar Institute wins $15M+ NIH investment to advance HIV cure research strategies
The Wistar Institute has announced the National Institutes of Health (NIH) has awarded two major grants totaling more than $15M to Luis J. Montaner, D.V.M., D.Phil., director of Wistar’s HIV Cure and Viral Diseases Center.
-
NewsThese bacteria can change their diet to survive inside the body
The team have found that Staphylococcus aureus can adjust its diet depending on what sources remain available. The bacterium can adjust its inner workings in response to any one of a number of different sulfur-containing compounds — like cysteine, glutathione or thiosulfate.
-
NewsResearchers discover highly potent compound that blocks Ebola virus entry
A research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus’s entry protein and provides strong protection when given orally in a preclinical model. It is more than 100 times more potent than previously reported Ebola entry inhibitors.
-
NewsC. diff coordinates threat response to survive in gut
Researchers have discovered a unique system C. diff uses to simultaneously sense and respond to two different threats: host-mediated nutrient deprivation and a microbiota-produced antibiotic compound, suggesting new therapeutic options for preventing and treating C. diff infections.
-
NewsEngineering bacterial surfaces with glucan nanofilms creates a potent vaccine platform against invasive fungal infections
A research team has developed a synthetic bacterium-based vaccine platform that uses engineered bacterial surfaces to assemble glucan nanofilms for enhanced antifungal immunity against pathogens such as Candida albicans.
-
NewsFusobacterium nucleatum drives immunosuppression and metastasis in TNBC
A new study identifies Fusobacterium nucleatum, a Gram-negative anaerobic bacterium associated with several cancers, as a key driver of tryptophan metabolic reprogramming, immunosuppression and lung metastasis in triple-negative breast cancer.
-
NewsA pan-sRNome analysis identifies novel regulatory small RNAs involved in Pseudomonas aeruginosa virulence
A characterization of nine newly discovered sRNAs reveals their regulatory networks in quorum sensing, biofilm formation, and interbacterial competition in Pseudomonas aeruginosa.
-
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
-
NewsNew study details the finding of the first known live kissing bug in Europe
Students taking a Medical Entomology class donned their detective hats and helped investigate what appears to be the first documented live kissing bug in Europe.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsSymposium commemorating the 50th anniversary of the discovery of the Hantaan virus successfully held
A symposium commemorating the 50th anniversary of the discovery of the Hantaan virus celebrated the historical achievement of the late Dr. Lee Ho-wang and reviewed the historical significance of Hantaan virus research, its results, and future infectious disease response strategies.
-
NewsPlant health: New joint factsheet outlines synergy between Horizon Europe projects FORSAID, CERBERUS and STELLA
One of the biggest threats to Europe’s forests and farms is the spread of biotic stressors, capable of reversing decades of cultivation and conservation. As part of its efforts to address this challenge, the EU has mobilised three sister projects - FORSAID, CERBERUS and STELLA.
-
-
NewsHelicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide
Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study - and those born in more recent decades may be more at risk of the disease after exposure.
-
NewsVaccine protects against multiple fungal infections without hurting the gut
A vaccine created to battle multiple life-threatening fungal infections is successful in achieving protective immunity in pre-clinical animal models while also maintaining the biodiversity of the gut microbiome, according to a new study.
-
NewsFaster diagnostics, deeper insights: Researchers strengthen response to Ebola outbreaks
Two studies provide important insights into the challenges of responding to outbreaks - one demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer cross-protection.
-
NewsCommonly used cancer drugs boost MRSA antibiotics – new research
Scientists tested five anti-cancer drugs and revealed that four of them helped penicillin-type antibiotics to kill MRSA. These drugs interfere with the bacteria’s ability to make DNA, making the bacteria more vulnerable to the antibiotics.
-
NewsResearch explores why strep throat can linger, even after treatment with antibiotics
Streptococcal sore throat can linger even after treatment, turning otherwise healthy children into carriers. Using whole genome sequencing, researchers hope to discover why.